articleCancer CellMay 1, 2011BRONZE OA

CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant

HSHiroshi SakamotoTTToshiyuki TsukaguchiSHSayuri HiroshimaTKTatsushi KodamaTKTakamitsu Kobayashi

KAN Research Institute

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

624
total citations
FWCI
35.63
Percentile
100%
References
50
Citations per year

Authors

10

Topics & keywords

Topics
Keywords
  • Anaplastic lymphoma kinase
  • Cancer research
  • ALK inhibitor
  • Crizotinib
  • Fusion gene
  • Mutation
  • Tyrosine kinase
  • In vitro
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding